Life

Chikungunya vaccine developed by Butantan is safe and generates sustained immune response in 96% of volunteers, study finds – GZH

Written by admin

  1. Chikungunya vaccine developed by Butantan is safe and generates sustained immune response in 96% of volunteers, study findsGZH
  2. Chikungunya vaccine is 96% effective, says ButantanLive well
  3. Rio Preto study attests to the effectiveness of the chikungunya vaccine in the United StatesNewspaper of the region
  4. Chikungunya vaccine generates immune response in 96% of volunteers, Butantan saysMetro1
  5. Butantan Releases Chikungunya Vaccine Test ResultsBrazil Television
  6. See full coverage on Google News

About the author

admin

Leave a Comment